Four had abnormal dopamine transporter imaging (DAT scan), suggesting that the observed clinical parkinsonian features were due to PD, rather than prior neuroleptic medication, although detailed medication usage was absent in the majority. This evidence concerns the gene SLC6A3 and Parkinson disease.